1 Study Coverage 1.1 Escitalopram Tablets Product Introduction 1.2 Market by Type 1.2.1 Global Escitalopram Tablets Market Size Growth Rate by Type 1.2.2 5mg/Pcs 1.2.3 10mg/Pcs 1.2.4 20mg/Pcs 1.3 Market by Application 1.3.1 Global Escitalopram Tablets Market Size Growth Rate by Application 1.3.2 Children 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Escitalopram Tablets Market Size, Estimates and Forecasts 2.1.1 Global Escitalopram Tablets Revenue 2016-2027 2.1.2 Global Escitalopram Tablets Sales 2016-2027 2.2 Global Escitalopram Tablets, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Escitalopram Tablets Historical Market Size by Region (2016-2021) 2.3.1 Global Escitalopram Tablets Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Escitalopram Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Escitalopram Tablets Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Escitalopram Tablets Sales Forecast by Region (2022-2027) 2.4.2 Global Escitalopram Tablets Revenue Forecast by Region (2022-2027) 3 Global Escitalopram Tablets Competitor Landscape by Players 3.1 Global Top Escitalopram Tablets Manufacturers by Sales 3.1.1 Global Escitalopram Tablets Sales by Manufacturer (2016-2021) 3.1.2 Global Escitalopram Tablets Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Escitalopram Tablets Manufacturers by Revenue 3.2.1 Key Escitalopram Tablets Manufacturers Covered: Ranking by Revenue 3.2.2 Global Escitalopram Tablets Revenue by Manufacturers (2016-2021) 3.2.3 Global Escitalopram Tablets Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Escitalopram Tablets Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Escitalopram Tablets Revenue in 2020 3.2.6 Global Escitalopram Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Escitalopram Tablets Price by Manufacturers 3.4 Global Escitalopram Tablets Manufacturing Base Distribution, Product Types 3.4.1 Escitalopram Tablets Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Escitalopram Tablets Product Type 3.4.3 Date of International Manufacturers Enter into Escitalopram Tablets Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Escitalopram Tablets Market Size by Type (2016-2021) 4.1.1 Global Escitalopram Tablets Sales by Type (2016-2021) 4.1.2 Global Escitalopram Tablets Revenue by Type (2016-2021) 4.1.3 Escitalopram Tablets Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Escitalopram Tablets Market Size Forecast by Type (2022-2027) 4.2.1 Global Escitalopram Tablets Sales Forecast by Type (2022-2027) 4.2.2 Global Escitalopram Tablets Revenue Forecast by Type (2022-2027) 4.2.3 Escitalopram Tablets Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Escitalopram Tablets Market Size by Application (2016-2021) 5.1.1 Global Escitalopram Tablets Sales by Application (2016-2021) 5.1.2 Global Escitalopram Tablets Revenue by Application (2016-2021) 5.1.3 Escitalopram Tablets Price by Application (2016-2021) 5.2 Escitalopram Tablets Market Size Forecast by Application (2022-2027) 5.2.1 Global Escitalopram Tablets Sales Forecast by Application (2022-2027) 5.2.2 Global Escitalopram Tablets Revenue Forecast by Application (2022-2027) 5.2.3 Global Escitalopram Tablets Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Escitalopram Tablets Market Size YoY Growth 2016-2027 6.1.1 China Escitalopram Tablets Sales YoY Growth 2016-2027 6.1.2 China Escitalopram Tablets Revenue YoY Growth 2016-2027 6.1.3 China Escitalopram Tablets Market Share in Global Market 2016-2027 6.2 China Escitalopram Tablets Market Size by Players (International and Local Players) 6.2.1 China Top Escitalopram Tablets Players by Sales (2016-2021) 6.2.2 China Top Escitalopram Tablets Players by Revenue (2016-2021) 6.3 China Escitalopram Tablets Historic Market Review by Type (2016-2021) 6.3.1 China Escitalopram Tablets Sales Market Share by Type (2016-2021) 6.3.2 China Escitalopram Tablets Revenue Market Share by Type (2016-2021) 6.3.3 China Escitalopram Tablets Price by Type (2016-2021) 6.4 China Escitalopram Tablets Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Escitalopram Tablets Sales Forecast by Type (2022-2027) 6.4.2 China Escitalopram Tablets Revenue Forecast by Type (2022-2027) 6.4.3 China Escitalopram Tablets Price Forecast by Type (2022-2027) 6.5 China Escitalopram Tablets Historic Market Review by Application (2016-2021) 6.5.1 China Escitalopram Tablets Sales Market Share by Application (2016-2021) 6.5.2 China Escitalopram Tablets Revenue Market Share by Application (2016-2021) 6.5.3 China Escitalopram Tablets Price by Application (2016-2021) 6.6 China Escitalopram Tablets Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Escitalopram Tablets Sales Forecast by Application (2022-2027) 6.6.2 China Escitalopram Tablets Revenue Forecast by Application (2022-2027) 6.6.3 China Escitalopram Tablets Price Forecast by Application (2022-2027) 7 North America 7.1 North America Escitalopram Tablets Market Size YoY Growth 2016-2027 7.2 North America Escitalopram Tablets Market Facts & Figures by Country 7.2.1 North America Escitalopram Tablets Sales by Country (2016-2021) 7.2.2 North America Escitalopram Tablets Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Escitalopram Tablets Market Size YoY Growth 2016-2027 8.2 Asia Pacific Escitalopram Tablets Market Facts & Figures by Region 8.2.1 Asia Pacific Escitalopram Tablets Sales by Region (2016-2021) 8.2.2 Asia Pacific Escitalopram Tablets Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Escitalopram Tablets Market Size YoY Growth 2016-2027 9.2 Europe Escitalopram Tablets Market Facts & Figures by Country 9.2.1 Europe Escitalopram Tablets Sales by Country (2016-2021) 9.2.2 Europe Escitalopram Tablets Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Escitalopram Tablets Market Size YoY Growth 2016-2027 10.2 Latin America Escitalopram Tablets Market Facts & Figures by Country 10.2.1 Latin America Escitalopram Tablets Sales by Country (2016-2021) 10.2.2 Latin America Escitalopram Tablets Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Escitalopram Tablets Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Escitalopram Tablets Market Facts & Figures by Country 11.2.1 Middle East and Africa Escitalopram Tablets Sales by Country (2016-2021) 11.2.2 Middle East and Africa Escitalopram Tablets Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Lundbeck (DK) 12.1.1 Lundbeck (DK) Corporation Information 12.1.2 Lundbeck (DK) Description and Business Overview 12.1.3 Lundbeck (DK) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Lundbeck (DK) Escitalopram Tablets Products Offered 12.1.5 Lundbeck (DK) Recent Development 12.2 Amneal Pharmaceuticals (US) 12.2.1 Amneal Pharmaceuticals (US) Corporation Information 12.2.2 Amneal Pharmaceuticals (US) Description and Business Overview 12.2.3 Amneal Pharmaceuticals (US) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Amneal Pharmaceuticals (US) Escitalopram Tablets Products Offered 12.2.5 Amneal Pharmaceuticals (US) Recent Development 12.3 Forest Laboratories (US) 12.3.1 Forest Laboratories (US) Corporation Information 12.3.2 Forest Laboratories (US) Description and Business Overview 12.3.3 Forest Laboratories (US) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Forest Laboratories (US) Escitalopram Tablets Products Offered 12.3.5 Forest Laboratories (US) Recent Development 12.4 TEVA (Israel) 12.4.1 TEVA (Israel) Corporation Information 12.4.2 TEVA (Israel) Description and Business Overview 12.4.3 TEVA (Israel) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.4.4 TEVA (Israel) Escitalopram Tablets Products Offered 12.4.5 TEVA (Israel) Recent Development 12.5 Mylan (US) 12.5.1 Mylan (US) Corporation Information 12.5.2 Mylan (US) Description and Business Overview 12.5.3 Mylan (US) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Mylan (US) Escitalopram Tablets Products Offered 12.5.5 Mylan (US) Recent Development 12.6 Silarx Pharmacueticals (US) 12.6.1 Silarx Pharmacueticals (US) Corporation Information 12.6.2 Silarx Pharmacueticals (US) Description and Business Overview 12.6.3 Silarx Pharmacueticals (US) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Silarx Pharmacueticals (US) Escitalopram Tablets Products Offered 12.6.5 Silarx Pharmacueticals (US) Recent Development 12.7 Apotex (CA) 12.7.1 Apotex (CA) Corporation Information 12.7.2 Apotex (CA) Description and Business Overview 12.7.3 Apotex (CA) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Apotex (CA) Escitalopram Tablets Products Offered 12.7.5 Apotex (CA) Recent Development 12.8 Lupin (IN) 12.8.1 Lupin (IN) Corporation Information 12.8.2 Lupin (IN) Description and Business Overview 12.8.3 Lupin (IN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Lupin (IN) Escitalopram Tablets Products Offered 12.8.5 Lupin (IN) Recent Development 12.9 Novartis (US) 12.9.1 Novartis (US) Corporation Information 12.9.2 Novartis (US) Description and Business Overview 12.9.3 Novartis (US) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Novartis (US) Escitalopram Tablets Products Offered 12.9.5 Novartis (US) Recent Development 12.10 Hikma Pharmaceuticals (UK) 12.10.1 Hikma Pharmaceuticals (UK) Corporation Information 12.10.2 Hikma Pharmaceuticals (UK) Description and Business Overview 12.10.3 Hikma Pharmaceuticals (UK) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Hikma Pharmaceuticals (UK) Escitalopram Tablets Products Offered 12.10.5 Hikma Pharmaceuticals (UK) Recent Development 12.11 Lundbeck (DK) 12.11.1 Lundbeck (DK) Corporation Information 12.11.2 Lundbeck (DK) Description and Business Overview 12.11.3 Lundbeck (DK) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Lundbeck (DK) Escitalopram Tablets Products Offered 12.11.5 Lundbeck (DK) Recent Development 12.12 Hetero Drugs (IN) 12.12.1 Hetero Drugs (IN) Corporation Information 12.12.2 Hetero Drugs (IN) Description and Business Overview 12.12.3 Hetero Drugs (IN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Hetero Drugs (IN) Products Offered 12.12.5 Hetero Drugs (IN) Recent Development 12.13 Accord Healthcare (IN) 12.13.1 Accord Healthcare (IN) Corporation Information 12.13.2 Accord Healthcare (IN) Description and Business Overview 12.13.3 Accord Healthcare (IN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Accord Healthcare (IN) Products Offered 12.13.5 Accord Healthcare (IN) Recent Development 12.14 Macleods Pharmaceuticals (IN) 12.14.1 Macleods Pharmaceuticals (IN) Corporation Information 12.14.2 Macleods Pharmaceuticals (IN) Description and Business Overview 12.14.3 Macleods Pharmaceuticals (IN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Macleods Pharmaceuticals (IN) Products Offered 12.14.5 Macleods Pharmaceuticals (IN) Recent Development 12.15 Xian Janssen Pharmaceutical (CN) 12.15.1 Xian Janssen Pharmaceutical (CN) Corporation Information 12.15.2 Xian Janssen Pharmaceutical (CN) Description and Business Overview 12.15.3 Xian Janssen Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Xian Janssen Pharmaceutical (CN) Products Offered 12.15.5 Xian Janssen Pharmaceutical (CN) Recent Development 12.16 Jewim Pharmaceutical (Shandong) 12.16.1 Jewim Pharmaceutical (Shandong) Corporation Information 12.16.2 Jewim Pharmaceutical (Shandong) Description and Business Overview 12.16.3 Jewim Pharmaceutical (Shandong) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Jewim Pharmaceutical (Shandong) Products Offered 12.16.5 Jewim Pharmaceutical (Shandong) Recent Development 12.17 Sichuan Kelun Pharmaceutical (CN) 12.17.1 Sichuan Kelun Pharmaceutical (CN) Corporation Information 12.17.2 Sichuan Kelun Pharmaceutical (CN) Description and Business Overview 12.17.3 Sichuan Kelun Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Sichuan Kelun Pharmaceutical (CN) Products Offered 12.17.5 Sichuan Kelun Pharmaceutical (CN) Recent Development 12.18 Hunan Dongting Pharmaceutical (CN) 12.18.1 Hunan Dongting Pharmaceutical (CN) Corporation Information 12.18.2 Hunan Dongting Pharmaceutical (CN) Description and Business Overview 12.18.3 Hunan Dongting Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Hunan Dongting Pharmaceutical (CN) Products Offered 12.18.5 Hunan Dongting Pharmaceutical (CN) Recent Development 12.19 Zhejiang Conba Pharmaceutical (CN) 12.19.1 Zhejiang Conba Pharmaceutical (CN) Corporation Information 12.19.2 Zhejiang Conba Pharmaceutical (CN) Description and Business Overview 12.19.3 Zhejiang Conba Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Zhejiang Conba Pharmaceutical (CN) Products Offered 12.19.5 Zhejiang Conba Pharmaceutical (CN) Recent Development 12.20 Xidian Pharmaceutical (CN) 12.20.1 Xidian Pharmaceutical (CN) Corporation Information 12.20.2 Xidian Pharmaceutical (CN) Description and Business Overview 12.20.3 Xidian Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Xidian Pharmaceutical (CN) Products Offered 12.20.5 Xidian Pharmaceutical (CN) Recent Development 12.21 Zhejiang Huahai Pharmaceutical (CN) 12.21.1 Zhejiang Huahai Pharmaceutical (CN) Corporation Information 12.21.2 Zhejiang Huahai Pharmaceutical (CN) Description and Business Overview 12.21.3 Zhejiang Huahai Pharmaceutical (CN) Escitalopram Tablets Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Zhejiang Huahai Pharmaceutical (CN) Products Offered 12.21.5 Zhejiang Huahai Pharmaceutical (CN) Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Escitalopram Tablets Industry Trends 13.2 Escitalopram Tablets Market Drivers 13.3 Escitalopram Tablets Market Challenges 13.4 Escitalopram Tablets Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Escitalopram Tablets Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Escitalopram Tablets Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 5mg/Pcs Table 3. Major Manufacturers of 10mg/Pcs Table 4. Major Manufacturers of 20mg/Pcs Table 5. Global Escitalopram Tablets Market Size Growth Rate by Application (2021-2027) & (M Pcs) Table 6. Global Escitalopram Tablets Market Size by Region (M Pcs) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Escitalopram Tablets Sales by Regions (2016-2021) & (M Pcs) Table 8. Global Escitalopram Tablets Sales Market Share by Regions (2016-2021) Table 9. Global Escitalopram Tablets Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Escitalopram Tablets Sales Forecast by Region (2022-2027) & (M Pcs) Table 11. Global Escitalopram Tablets Sales Market Share Forecast by Region (2022-2027) Table 12. Global Escitalopram Tablets Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Escitalopram Tablets Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Escitalopram Tablets Sales by Manufacturers (2016-2021) (M Pcs) Table 15. Global Escitalopram Tablets Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Escitalopram Tablets Manufacturers by Revenue (US$ Million) in 2020 Table 17. Escitalopram Tablets Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Escitalopram Tablets Revenue Share by Manufacturers (2016-2021) Table 19. Global Escitalopram Tablets Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Escitalopram Tablets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Escitalopram Tablets as of 2020) Table 21. Key Manufacturers Escitalopram Tablets Price (2016-2021) (US$/K Pcs) Table 22. Escitalopram Tablets Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Escitalopram Tablets Product Type Table 24. Date of International Manufacturers Enter into Escitalopram Tablets Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Escitalopram Tablets Sales by Type (2016-2021) (M Pcs) Table 27. Global Escitalopram Tablets Sales Share by Type (2016-2021) Table 28. Global Escitalopram Tablets Revenue by Type (2016-2021) (US$ Million) Table 29. Global Escitalopram Tablets Revenue Share by Type (2016-2021) Table 30. Escitalopram Tablets Average Selling Price (ASP) by Type (2016-2021) & (US$/K Pcs) Table 31. Global Escitalopram Tablets Sales Forecast by Type (2022-2027) & (M Pcs) Table 32. Global Escitalopram Tablets Sales Market Share Forecast by Type (2022-2027) Table 33. Global Escitalopram Tablets Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Escitalopram Tablets Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Escitalopram Tablets Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/K Pcs) Table 36. Global Escitalopram Tablets Sales by Application (2016-2021) (M Pcs) Table 37. Global Escitalopram Tablets Sales Share by Application (2016-2021) Table 38. Global Escitalopram Tablets Revenue by Application (2016-2021) (US$ Million) Table 39. Global Escitalopram Tablets Revenue Share by Application (2016-2021) Table 40. Escitalopram Tablets Average Selling Price (ASP) by Application (2016-2021) & (US$/K Pcs) Table 41. Global Escitalopram Tablets Sales Forecast by Application (2022-2027) & (M Pcs) Table 42. Global Escitalopram Tablets Sales Market Share Forecast by Application (2022-2027) Table 43. Global Escitalopram Tablets Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Escitalopram Tablets Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Escitalopram Tablets Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/K Pcs) Table 46. China Escitalopram Tablets Sales (M Pcs) of Key Companies (2016-2021) Table 47. China Escitalopram Tablets Sales Share by Company (2016-2021) Table 48. China Escitalopram Tablets Revenue (US$ Million) by Company (2016-2021) Table 49. China Escitalopram Tablets Revenue Share by Company (2016-2021) Table 50. China Escitalopram Tablets Sales (M Pcs) by Type (2016-2021) Table 51. China Escitalopram Tablets Sales Share by Type (2016-2021) Table 52. China Escitalopram Tablets Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Escitalopram Tablets Price (US$/K Pcs) by Type (2016-2021) Table 54. China Escitalopram Tablets Sales (M Pcs) by Type (2022-2027) Table 55. China Escitalopram Tablets Sales Share by Type (2022-2027) Table 56. China Escitalopram Tablets Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Escitalopram Tablets Revenue Share by Type (2022-2027) Table 58. China Escitalopram Tablets Price (US$/K Pcs) by Type (2022-2027) Table 59. China Escitalopram Tablets Sales (M Pcs) by Application (2016-2021) Table 60. China Escitalopram Tablets Sales Share by Application (2016-2021) Table 61. China Escitalopram Tablets Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Escitalopram Tablets Price (US$/K Pcs) by Application (2016-2021) Table 63. China Escitalopram Tablets Sales (M Pcs) by Application (2022-2027) Table 64. China Escitalopram Tablets Sales Share by Application (2022-2027) Table 65. China Escitalopram Tablets Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Escitalopram Tablets Revenue Share by Application (2022-2027) Table 67. China Escitalopram Tablets Price (US$/K Pcs) by Application (2022-2027) Table 68. North America Escitalopram Tablets Sales by Country (2016-2021) & (M Pcs) Table 69. North America Escitalopram Tablets Sales Market Share by Country (2016-2021) Table 70. North America Escitalopram Tablets Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Escitalopram Tablets Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Escitalopram Tablets Sales by Region (2016-2021) & (M Pcs) Table 73. Asia Pacific Escitalopram Tablets Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Escitalopram Tablets Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Escitalopram Tablets Revenue Market Share by Region (2016-2021) Table 76. Europe Escitalopram Tablets Sales by Country (2016-2021) & (M Pcs) Table 77. Europe Escitalopram Tablets Sales Market Share by Country (2016-2021) Table 78. Europe Escitalopram Tablets Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Escitalopram Tablets Revenue Market Share by Country (2016-2021) Table 80. Latin America Escitalopram Tablets Sales by Country (2016-2021) & (M Pcs) Table 81. Latin America Escitalopram Tablets Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Escitalopram Tablets Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Escitalopram Tablets Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Escitalopram Tablets Sales by Country (2016-2021) & (M Pcs) Table 85. Middle East and Africa Escitalopram Tablets Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Escitalopram Tablets Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Escitalopram Tablets Revenue Market Share by Country (2016-2021) Table 88. Lundbeck (DK) Corporation Information Table 89. Lundbeck (DK) Description and Business Overview Table 90. Lundbeck (DK) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 91. Lundbeck (DK) Escitalopram Tablets Product Table 92. Lundbeck (DK) Recent Development Table 93. Amneal Pharmaceuticals (US) Corporation Information Table 94. Amneal Pharmaceuticals (US) Description and Business Overview Table 95. Amneal Pharmaceuticals (US) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 96. Amneal Pharmaceuticals (US) Product Table 97. Amneal Pharmaceuticals (US) Recent Development Table 98. Forest Laboratories (US) Corporation Information Table 99. Forest Laboratories (US) Description and Business Overview Table 100. Forest Laboratories (US) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 101. Forest Laboratories (US) Product Table 102. Forest Laboratories (US) Recent Development Table 103. TEVA (Israel) Corporation Information Table 104. TEVA (Israel) Description and Business Overview Table 105. TEVA (Israel) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 106. TEVA (Israel) Product Table 107. TEVA (Israel) Recent Development Table 108. Mylan (US) Corporation Information Table 109. Mylan (US) Description and Business Overview Table 110. Mylan (US) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 111. Mylan (US) Product Table 112. Mylan (US) Recent Development Table 113. Silarx Pharmacueticals (US) Corporation Information Table 114. Silarx Pharmacueticals (US) Description and Business Overview Table 115. Silarx Pharmacueticals (US) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 116. Silarx Pharmacueticals (US) Product Table 117. Silarx Pharmacueticals (US) Recent Development Table 118. Apotex (CA) Corporation Information Table 119. Apotex (CA) Description and Business Overview Table 120. Apotex (CA) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 121. Apotex (CA) Product Table 122. Apotex (CA) Recent Development Table 123. Lupin (IN) Corporation Information Table 124. Lupin (IN) Description and Business Overview Table 125. Lupin (IN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 126. Lupin (IN) Product Table 127. Lupin (IN) Recent Development Table 128. Novartis (US) Corporation Information Table 129. Novartis (US) Description and Business Overview Table 130. Novartis (US) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 131. Novartis (US) Product Table 132. Novartis (US) Recent Development Table 133. Hikma Pharmaceuticals (UK) Corporation Information Table 134. Hikma Pharmaceuticals (UK) Description and Business Overview Table 135. Hikma Pharmaceuticals (UK) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 136. Hikma Pharmaceuticals (UK) Product Table 137. Hikma Pharmaceuticals (UK) Recent Development Table 138. Aurobindo Pharma (IN) Corporation Information Table 139. Aurobindo Pharma (IN) Description and Business Overview Table 140. Aurobindo Pharma (IN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 141. Aurobindo Pharma (IN) Product Table 142. Aurobindo Pharma (IN) Recent Development Table 143. Hetero Drugs (IN) Corporation Information Table 144. Hetero Drugs (IN) Description and Business Overview Table 145. Hetero Drugs (IN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 146. Hetero Drugs (IN) Product Table 147. Hetero Drugs (IN) Recent Development Table 148. Accord Healthcare (IN) Corporation Information Table 149. Accord Healthcare (IN) Description and Business Overview Table 150. Accord Healthcare (IN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 151. Accord Healthcare (IN) Product Table 152. Accord Healthcare (IN) Recent Development Table 153. Macleods Pharmaceuticals (IN) Corporation Information Table 154. Macleods Pharmaceuticals (IN) Description and Business Overview Table 155. Macleods Pharmaceuticals (IN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 156. Macleods Pharmaceuticals (IN) Product Table 157. Macleods Pharmaceuticals (IN) Recent Development Table 158. Xian Janssen Pharmaceutical (CN) Corporation Information Table 159. Xian Janssen Pharmaceutical (CN) Description and Business Overview Table 160. Xian Janssen Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 161. Xian Janssen Pharmaceutical (CN) Product Table 162. Xian Janssen Pharmaceutical (CN) Recent Development Table 163. Jewim Pharmaceutical (Shandong) Corporation Information Table 164. Jewim Pharmaceutical (Shandong) Description and Business Overview Table 165. Jewim Pharmaceutical (Shandong) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 166. Jewim Pharmaceutical (Shandong) Product Table 167. Jewim Pharmaceutical (Shandong) Recent Development Table 168. Sichuan Kelun Pharmaceutical (CN) Corporation Information Table 169. Sichuan Kelun Pharmaceutical (CN) Description and Business Overview Table 170. Sichuan Kelun Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 171. Sichuan Kelun Pharmaceutical (CN) Product Table 172. Sichuan Kelun Pharmaceutical (CN) Recent Development Table 173. Hunan Dongting Pharmaceutical (CN) Corporation Information Table 174. Hunan Dongting Pharmaceutical (CN) Description and Business Overview Table 175. Hunan Dongting Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 176. Hunan Dongting Pharmaceutical (CN) Product Table 177. Hunan Dongting Pharmaceutical (CN) Recent Development Table 178. Zhejiang Conba Pharmaceutical (CN) Corporation Information Table 179. Zhejiang Conba Pharmaceutical (CN) Description and Business Overview Table 180. Zhejiang Conba Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 181. Zhejiang Conba Pharmaceutical (CN) Product Table 182. Zhejiang Conba Pharmaceutical (CN) Recent Development Table 183. Xidian Pharmaceutical (CN) Corporation Information Table 184. Xidian Pharmaceutical (CN) Description and Business Overview Table 185. Xidian Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 186. Xidian Pharmaceutical (CN) Product Table 187. Xidian Pharmaceutical (CN) Recent Development Table 188. Zhejiang Huahai Pharmaceutical (CN) Corporation Information Table 189. Zhejiang Huahai Pharmaceutical (CN) Description and Business Overview Table 190. Zhejiang Huahai Pharmaceutical (CN) Escitalopram Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2016-2021) Table 191. Zhejiang Huahai Pharmaceutical (CN) Product Table 192. Zhejiang Huahai Pharmaceutical (CN) Recent Development Table 193. Escitalopram Tablets Market Trends Table 194. Escitalopram Tablets Market Drivers Table 195. Escitalopram Tablets Market Challenges Table 196. Escitalopram Tablets Market Restraints Table 197. Escitalopram Tablets Customers List Table 198. Escitalopram Tablets Distributors List Table 199. Research Programs/Design for This Report Table 200. Key Data Information from Secondary Sources Table 201. Key Data Information from Primary Sources List of Figures Figure 1. Escitalopram Tablets Product Picture Figure 2. Global Escitalopram Tablets Sales Market Share by Type in 2020 & 2027 Figure 3. 5mg/Pcs Product Picture Figure 4. 10mg/Pcs Product Picture Figure 5. 20mg/Pcs Product Picture Figure 6. Global Escitalopram Tablets Sales Market Share by Application in 2020 & 2027 Figure 7. Children Figure 8. Adults Figure 9. Escitalopram Tablets Report Years Considered Figure 10. Global Escitalopram Tablets Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Escitalopram Tablets Market Size 2016-2027 (US$ Million) Figure 12. Global Escitalopram Tablets Sales 2016-2027 (M Pcs) Figure 13. Global Escitalopram Tablets Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Escitalopram Tablets Sales Market Share by Region (2016-2021) Figure 15. Global Escitalopram Tablets Sales Market Share by Region in 2020 Figure 16. Global Escitalopram Tablets Revenue Market Share by Region (2016-2021) Figure 17. Global Escitalopram Tablets Revenue Market Share by Region in 2020 Figure 18. Global Escitalopram Tablets Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Escitalopram Tablets Revenue in 2020 Figure 20. Escitalopram Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Escitalopram Tablets Sales Market Share by Type (2016-2021) Figure 22. Global Escitalopram Tablets Sales Market Share by Type in 2020 Figure 23. Global Escitalopram Tablets Revenue Market Share by Type (2016-2021) Figure 24. Global Escitalopram Tablets Revenue Market Share by Type in 2020 Figure 25. Global Escitalopram Tablets Sales Market Share by Application (2016-2021) Figure 26. Global Escitalopram Tablets Sales Market Share by Application in 2020 Figure 27. Global Escitalopram Tablets Revenue Market Share by Application (2016-2021) Figure 28. Global Escitalopram Tablets Revenue Market Share by Application in 2020 Figure 29. China Escitalopram Tablets Sales Growth Rate 2016-2027 (M Pcs) Figure 30. China Escitalopram Tablets Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China Escitalopram Tablets Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest Escitalopram Tablets Players Market Share by Revenue in Escitalopram Tablets in 2020 Figure 33. China Escitalopram Tablets Revenue Share by Type (2016-2021) Figure 34. China Escitalopram Tablets Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China Escitalopram Tablets Revenue Share by Application (2016-2021) Figure 36. China Escitalopram Tablets Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Escitalopram Tablets Sales Growth Rate 2016-2021 (M Pcs) Figure 38. North America Escitalopram Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Escitalopram Tablets Sales Market Share by Country in 2020 Figure 40. North America Escitalopram Tablets Revenue Market Share by Country in 2020 Figure 41. United States Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 42. United States Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 44. Canada Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Escitalopram Tablets Sales Growth Rate 2016-2021 (M Pcs) Figure 46. Europe Escitalopram Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Escitalopram Tablets Sales Market Share by Country in 2020 Figure 48. Europe Escitalopram Tablets Revenue Market Share by Country in 2020 Figure 49. Germany Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 50. Germany Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 52. France Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 54. U.K. Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 56. Italy Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 58. Russia Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Escitalopram Tablets Sales Growth Rate 2016-2021 (M Pcs) Figure 60. Asia Pacific Escitalopram Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Escitalopram Tablets Sales Market Share by Region in 2020 Figure 62. Asia Pacific Escitalopram Tablets Revenue Market Share by Region in 2020 Figure 63. China Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 64. China Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 66. Japan Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 68. South Korea Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 70. India Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 72. Australia Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. China Taiwan Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 74. China Taiwan Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 76. Indonesia Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 78. Thailand Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 80. Malaysia Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Latin America Escitalopram Tablets Sales Growth Rate 2016-2021 (M Pcs) Figure 82. Latin America Escitalopram Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 83. Latin America Escitalopram Tablets Sales Market Share by Country in 2020 Figure 84. Latin America Escitalopram Tablets Revenue Market Share by Country in 2020 Figure 85. Mexico Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 86. Mexico Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Brazil Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 88. Brazil Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Argentina Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 90. Argentina Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Middle East and Africa Escitalopram Tablets Sales Growth Rate 2016-2021 (M Pcs) Figure 92. Middle East and Africa Escitalopram Tablets Revenue Growth Rate 2016-2021 (US$ Million) Figure 93. Middle East and Africa Escitalopram Tablets Sales Market Share by Country in 2020 Figure 94. Middle East and Africa Escitalopram Tablets Revenue Market Share by Country in 2020 Figure 95. Turkey Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 96. Turkey Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Saudi Arabia Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 98. Saudi Arabia Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. UAE Escitalopram Tablets Sales Growth Rate (2016-2021) (M Pcs) Figure 100. UAE Escitalopram Tablets Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Escitalopram Tablets Value Chain Figure 102. Channels of Distribution Figure 103. Distributors Profiles Figure 104. Bottom-up and Top-down Approaches for This Report Figure 105. Data Triangulation Figure 106. Key Executives Interviewed

Lundbeck (DK) Amneal Pharmaceuticals (US) Forest Laboratories (US) TEVA (Israel) Mylan (US) Silarx Pharmacueticals (US) Apotex (CA) Lupin (IN) Novartis (US) Hikma Pharmaceuticals (UK) Aurobindo Pharma (IN) Hetero Drugs (IN) Accord Healthcare (IN) Macleods Pharmaceuticals (IN) Xian Janssen Pharmaceutical (CN) Jewim Pharmaceutical (Shandong) Sichuan Kelun Pharmaceutical (CN) Hunan Dongting Pharmaceutical (CN) Zhejiang Conba Pharmaceutical (CN) Xidian Pharmaceutical (CN) Zhejiang Huahai Pharmaceutical (CN)